WR
Wolfe Research Latest Price Targets & Analyst Ratings
# | Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
---|---|---|---|---|---|---|---|---|
1 |
1
Delek US
DK
$1.92B
|
DL
Doug Leggate
| $31.91 | $40 |
25%
upside
| Outperform | 12 hours ago |
|
2 |
2
CoStar Group
CSGP
$37.2B
|
SW
Scott Wurtzel
| $87.86 | $105 |
20%
upside
| Outperform | 13 hours ago |
|
3 |
3
Verisk Analytics
VRSK
$37.5B
|
SW
Scott Wurtzel
| $268.44 | $320 |
19%
upside
| Outperform | 13 hours ago |
|
4 |
4
MongoDB
MDB
$25.5B
|
AZ
Alex Zukin
| $312.88 | $350 |
12%
upside
| Outperform | 7 days ago |
|
5 |
5
Applied Materials
AMAT
$124B
|
CC
Chris Caso
| $156.25 | $200 |
28%
upside
| Outperform | 19 days ago |
|
6 |
AIV
6
Aimco
AIV
$1.1B
|
AR
Andrew Rosivach
| $7.76 | $10 |
29%
upside
| Outperform | 1 month ago |
|
7 |
7
Broadstone Net Lease
BNL
$3.52B
|
AR
Andrew Rosivach
| $18.61 | $19 |
2%
upside
| Outperform | 1 month ago |
|
8 |
8
Texas Instruments
TXN
$178B
|
CC
Chris Caso
| $195.74 | $230 |
18%
upside
| Outperform | 1 month ago |
|
9 |
9
Kinder Morgan
KMI
$59.4B
|
KS
Keith Stanley
| $26.73 | $31 |
16%
upside
| Outperform | 1 month ago |
|
10 |
10
General Dynamics
GD
$86.8B
|
MW
Myles Walton
| $322.81 | $360 |
12%
upside
| Outperform | 1 month ago |
|
11 |
CAI
11
Caris Life Sciences, Inc. Common Stock
CAI
$10.4B
|
DS
Doug Schenkel
| $36.80 | $32 |
13%
downside
| Outperform | 1 month ago |
|
12 |
12
Piper Sandler
PIPR
$5.7B
|
SC
Steven Chubak
| $322.37 | $339 |
5%
upside
| Outperform | 1 month ago |
|
13 |
VOYG
13
Voyager Technologies, Inc.
VOYG
$1.69B
|
MW
Myles Walton
| $28.70 | $50 |
74%
upside
| Outperform | 1 month ago |
|
14 |
CHYM
14
Chime Financial, Inc. Class A Common Stock
CHYM
$9.04B
| $24.31 | $38 |
56%
upside
| Outperform | 1 month ago |
|
|
15 |
15
Alliant Energy
LNT
$16.6B
|
SF
Steve Fleishman
| $64.52 | $68 |
5%
upside
| Outperform | 1 month ago |
|
16 |
VRNA
16
Verona Pharma
VRNA
$9.18B
|
AC
Andy Chen
| $106.17 | $170 |
60%
upside
| Outperform | 2 months ago |
|
17 |
17
TPG
TPG
$8.58B
|
SC
Steven Chubak
| $58.13 | $60 |
3%
upside
| Outperform | 2 months ago |
|
18 |
18
BridgeBio Pharma
BBIO
$9.91B
|
AC
Andy Chen
| $51.84 | $49 |
5%
downside
| Outperform | 2 months ago |
|
19 |
19
Avidity Biosciences
RNA
$6.12B
|
AC
Andy Chen
| $47.59 | $55 |
16%
upside
| Outperform | 2 months ago |
|
20 |
20
Comstock Resources
CRK
$4.63B
|
DL
Doug Leggate
| $15.81 | $34 |
115%
upside
| Outperform | 2 months ago |
|
21 |
21
Live Nation Entertainment
LYV
$37.6B
|
JJ
John Janedis
| $161.97 | $168 |
4%
upside
| Outperform | 2 months ago |
|
22 |
QXO
22
QXO Inc
QXO
$13.8B
|
TA
Trevor Allinson
| $20.53 | $44 |
114%
upside
| Outperform | 2 months ago |
|
23 |
BBNX
23
Beta Bionics, Inc. Common Stock
BBNX
$855M
|
MP
Mike Polark
| $19.68 | $20 |
2%
upside
| Outperform | 3 months ago |
|
24 |
24
UnitedHealth
UNH
$279B
|
JL
Justin Lake
| $307.88 | $390 |
27%
upside
| Outperform | 3 months ago |
|
25 |
25
LivaNova
LIVN
$3.09B
|
MP
Mike Polark
| $56.59 | $60 |
6%
upside
| Outperform | 3 months ago |
|